Sai Parenteral’s IPO is a Mainboard issue open from 24–27 March. The company is raising ₹409 Cr at a price band of ₹372 to ₹392 per share. One lot is 38 shares.
₹0
Implied listing gain: ₹400
0.01x
Times the issue was bid for
On the GMP figure: grey market premium is quoted by informal dealers. No exchange publishes it, no regulator oversees it, and it is not a forecast of the listing price. Issues quoting a strong premium have listed below their issue price. Weigh the financials and the risk factors in the RHP well above this number.
Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.
Minimum retail investment
₹14,896
38 shares at the upper band of ₹392
Retail limit
13 lots
the most that fits under the ₹2 lakh retail cap
Funds blocked after close
~6 days
from the closing date to listing
Total subscription
0.01x
across all categories
Sai Parenteral’s is a mainboard issue raising ₹409 Cr, offered in a band of ₹372–₹392 per share. At the upper end that is 78.4 times the ₹5 face value, so ₹387 of every share subscribed is share premium rather than capital.
A retail application for Sai Parenteral’s needs one lot of 38 shares, which works out to ₹14,896 at the upper band of ₹392. That is close to the ₹15,000 ceiling SEBI expects for a single retail lot, so an investor applying at cut-off is committing nearly the full retail limit per application. Retail applications are capped at ₹2,00,000, which here is 13 lots; bidding above that moves the application into the non-institutional category, and the large-HNI bucket begins at ₹10,00,000, or about 68 lots.
For Sai Parenteral’s, bidding runs 24-27 March, allotment is finalised on 30 March 2026, the shares list on 2 April 2026. Applications that do not receive an allotment have their UPI mandate released around 3 days after the issue closes. Counting from the close of bidding, money stays blocked for roughly 6 days before listing decides what the holding is worth.
The issue is reserved 50% to qualified institutional buyers, 15% to non-institutional investors, 35% to retail. A 35% retail share is the wider end of the range, which improves the odds for small applications when the book is only modestly oversubscribed. An oversubscribed retail portion is not allotted in proportion to the amount applied for: applications are reduced to single lots and drawn by lot, so several small applications from different PANs are more effective than one large one.
Subscription stands at 0.01x, which is below full. An issue must be subscribed at least once over to proceed at all; if it closes under that, the offer is withdrawn and all application money is refunded.
Bigshare Services Pvt. Ltd is the registrar for this issue, which means the allotment status for Sai Parenteral’s is published on their portal from 30 March 2026. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.
The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.
| IPO Date | 24–27 March |
| Face Value | ₹5 Per Share |
| Price Range | ₹372 to ₹392 |
| Issue Size | ₹409 Cr |
| Lot Size | 38 Shares |
| Allotment Date | 30 March 2026 |
| Listing Date | 2 April 2026 |
| Registrar | Bigshare Services Pvt. Ltd |
| Category | Allocation |
|---|---|
| Retail Investors | 35% |
| QIB (Qualified Institutional Buyers) | 50% |
| HNI (High Net Worth Individuals) | 15% |
Sai Parenteral’s IPO is a Mainboard issue open from 24–27 March. The company is raising ₹409 Cr at a price band of ₹372 to ₹392 per share. One lot is 38 shares.
The issue is open 24–27 March. Bids must be placed, and any UPI mandate approved, before the cut-off on the closing day.
The price band is ₹372 to ₹392 per equity share, against a face value of ₹5. Retail investors may bid at cut-off, meaning they accept the final discovered price within this band.
The minimum application is 38 shares, and bids must be in multiples of that lot.
The total issue size is ₹409 Cr.
The issue is reserved as retail 35%, QIB 50%, HNI 15%. If the retail portion is oversubscribed, allotment there is decided by a lottery on lot-sized applications rather than in proportion to the amount applied for.
Basis of allotment is expected to be finalised on 30 March 2026. You can check your status on the registrar's website (Bigshare Services Pvt. Ltd) using your PAN.
Listing is expected on 2 April 2026, following the T+3 timeline that applies to Indian IPOs.
This information is for educational purposes only. Please conduct your own research and consult with financial advisors before making investment decisions. IPO investments carry market risks.
Or see the full upcoming IPO list, today's grey market premium, subscription figures and allotment status.

HDFC Bank ke Chairman Atanu Chakraborty ne 18 March 2026 ko "values aur ethics" ka hawala dete hue istifa de diya. Stock 9% crash hua, ₹61,000 crore market cap ek jhatke mein gaya. Jaaniye poori kahani aur aapko kya karna chahiye.

Reliance Jio IPO 2026 mein India ka sabse bada IPO ban sakta hai — $180 billion valuation, $4.3 billion fundraise. Lekin abhi ek regulatory roadblock aaya hai. Jaaniye poori detail — date, price, GMP, aur kya aapko invest karna chahiye.

Option trading beginners ke liye confusing ho sakti hai. Is guide me hum samjhenge option trading kya hoti hai, kaise kaam karti hai aur beginners kaise safe tarike se options trading start kar sakte hain.